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Background: Preparation of inhaled capsaicin solutions for cough induction varies greatly from one lab to another,
which creates inconsistencies between tussigenic challenge results. The addition of Tween to these capsaicin
solutions provides increased solubility and stability; however, the foul taste of Tween makes inhaling the solution
for any prolonged period of time unpleasant. We sought to create a standard method for preparing soluble and
stable capsaicin-based solutions (in 10% ethanol/water), without the addition of Tween.
Methods: Capsaicin solutions were created at concentrations ranging from 0 to 500 μM in a variety of solvent
systems, with and without Tween. Samples were stored in four different environments (−20°C, 3°C, and room
temperature, protected from light; and room temperature, exposed to light) to test stability. Detection of capsaicin
was carried out by UV absorption. A Grubb’s test was performed on all data to remove statistical outliers.
Results: Similar capsaicin concentrations were seen for solutions prepared with or without Tween (Tween provided
a slight increase in solubility), with neither solvent system providing complete solubility. Of the four environments
tested, storing capsaicin solutions at 3°C while protected from light afforded the greatest stability, for a minimum of
30 weeks.
Conclusion: We recommend the use of a 10% ethanol/water solvent system without Tween in the preparation of
capsaicin solutions for tussigenic challenges. While this solvent system does not provide complete solubility, we
have detailed a method for capsaicin solution preparation that will account for this loss of solubility, while
maintaining a solution that is Tween-free and safe for human inhalation.
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Capsaicin (CAP) can be utilized to test the cough threshold
of patients thought to have certain respiratory diseases, as
well as healthy individuals [1-3]. The greatest challenges in
using CAP for such tests are its low solubility in water and
storage instability. Therefore, while a pure water solvent
system would be ideal for such solutions requiring human
consumption, water alone cannot be used since the
capsaicin does not dissolve in sufficient quantities to
afford meaningful testing. Hence, all of the reported
studies used solutions of capsaicin in water mixed with
low concentrations of organic solvents. Fortunately, CAP
has been shown to be completely soluble in organic
solvents, with ethanol (EtOH) providing the greatest* Correspondence: pdavenpo@ufl.edu
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unless otherwise stated.solubility [4,5]. Further research has revealed that dis-
solving CAP in a mixture of EtOH and polysorbate-80
(Tween-80) allows for a higher solubility than EtOH
without Tween [6-9]. Our own research suggests Tween-
20 is an equivalent replacement solvent for Tween-80;
thus, Tween-20 was utilized in this research.
CAP solutions containing Tween-20 have been pre-
pared and tested on subjects with well documented
dose–response relationships for cough reflex testing
[10-13]. Regrettably, there was a common complaint of
a bad taste from the solution, as reported in several
previous studies of Tween’s use in flavor detection and
awareness as the adverse stimulus [14-16]. This taste,
often described as soapy and unpleasant, can be attributed
to the presence of the surfactant, Tween-20 or Tween 80,
in solution. Since subjects are required to inhale CAP
solutions for an extended period of time, the taste of theal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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studies reported quantitative comparisons of CAP in solu-
tions with Tween versus solutions without Tween [6,7],
to the authors’ knowledge, there has yet to be a study
that directly compares the solubility of a broad range
of concentrations of CAP in 10% EtOH alone to CAP
in a Tween solution. Furthermore, a comparison of
CAP solubility in solutions of varying percentages of
EtOH has yet to be reported. The purpose of such a
comparison would be to produce CAP solutions in an
EtOH-based solvent system, equivalent to those deemed
fit for use in the aforementioned cough threshold tests
[1,3], but without Tween.
In this study, we sought to determine (1) the percentage
of EtOH yielding CAP solubility comparable to a desired
concentration of CAP in Tween-20 solution, (2) the con-
centration of CAP dissolved in 10% EtOH required to
produce analogous solubility to a desired concentration
of CAP in solution containing Tween-20, (3) if the ratio
of CAP present in EtOH solution to CAP present in
Tween-20 solution changes with variations in CAP con-
centration, and (4) the shelf life of CAP in 10% EtOH.
Based upon these results, we are now developing a
standardized method for optimal preparation of CAP
solutions for use in tussigenic challenges.Methods
Chemicals and reagents
Capsaicin, pharmaceutical grade, was purchased from
Formosa Labs (Taoyean, Taiwan) and stored at −20°C until
use. 190 proof ethyl alcohol (95% EtOH) was purchased
from Decon Labs (King of Prussia, PA). HPLC grade water
was purchased from Fischer-Scientific (Fair Lawn, NJ).
Tween-20 was purchased from MP Biomedicals (Solon,
OH). All solutions were stored at room temperature,
unless otherwise stated.
Prior to each study, a stock solution of 25 mM CAP
was prepared. Initially, the CAP powder was dissolved in
a solution made-up of 80:10:10 H2O:Tween-20:95%
EtOH (hereafter referred to as “Tween solution”), but
this method did not allow sufficient solubility of high
concentrations of CAP. Instead, the stock solution was
prepared by dissolving 76 mg (250 μmol) of solid CAP in
10 mL of 95% EtOH. Preparing such a high concentration
of CAP for the stock solution allowed any error associated
with variation of volume to be considered negligible. In
the research presented, solutions with EtOH levels at 5,
10, 15, 20, 25, 35, 50, 65, 75, and 95% EtOH in H2O were
prepared. Additionally, solutions of CAP were prepared at
concentrations of 0, 200, 350, and 500 μM for all percent-
ages of EtOH mentioned. Finally, a much broader range of
concentrations (0, 50, 100, 150, 200, 250, 300, 350, 400,
450, and 500 μM) were prepared in 10% EtOH for morein-depth analysis. All samples were diluted to a total
volume of 5 mL in triplicate.
To prepare the Tween solutions, a solution of 80:10:10 of
H2O:Tween-20:95% EtOH (v/v/v) was initially prepared.
To this Tween solution, a specified volume of 25 mM
stock CAP was added to achieve the desired concentration
of CAP. Solutions of CAP were prepared at concentrations
of 0, 50, 150, 250, 350, and 450 μM, with a total volume of
5 mL. Similar to the CAP solutions in EtOH, the Tween
solutions were prepared in triplicate.
To study the stability of CAP in the optimized solvent
system, solutions at concentrations of 0, 200, 350, and
500 μM CAP in 10% EtOH/H2O (without Tween-20)
were prepared, and left in one of four different environ-
ments: 1) room temperature and exposed to light, 2) room
temperature and protected from light, 3) approximately
3°C and protected from light, and 4) approximately −20°C
and protected from light. All solutions were kept in glass
vials, and placed in a cardboard box to shelter them from
light, except one set of vials which was directly exposed to
room light for the purposes of the study. For solutions
stored below room temperature (3°C and −20°C), the
solutions were allowed to warm up to room temperature
for two hours and then vortexed, before analysis. Visual
inspections of the solutions prior to analysis indicated no
turbidity. All samples were prepared in triplicate to a final
volume of 5 mL.
Determination of CAP concentration
The concentration of CAP in the solutions was mea-
sured by ultraviolet (UV) absorption spectrophotometry.
A Hewlett-Packard 8450A UV/Vis spectrophotometer
was utilized to monitor the absorbance at 281 nm [5].
Although the instrument offers automatic blank subtrac-
tion due to its double-beam geometry, blanks of the EtOH
solvent were analyzed separately from the samples, and
manual blank-subtraction was performed as the EtOH
signal was negligible. However, as Tween-20 exhibited
appreciable absorbance in the spectral region of interest,
the double-beam capabilities of the instrument were
exploited to perform blank-subtraction automatically.
To ensure removal of anomalous data, a Grubb’s test
with a confidence interval of P = 0.05 was performed on
any data suspected to be a statistical outlier. All outliers
were subsequently removed from the data set.
Results
Solubility of CAP in different solvent systems
Initially, the solubility of CAP in varying concentrations
of EtOH in H2O was evaluated. Figure 1 displays the
blank-corrected absorbance at 281 nm of CAP as a func-
tion of EtOH percentage present in the solvent. As
expected, the solubility of CAP increases with increasing
EtOH percentage; ramping the concentration of ethanol
Figure 1 The blank-corrected UV absorbance (λ = 281 nm) of 200, 350, and 500 μM CAP for varying compositions of ethanol. Error bars
correspond to ± 1 standard deviation.
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solubility.
The effect of a mixed solvent system containing both
Tween-20 and EtOH was also investigated. Figure 2
details the CAP absorbance response curve for threeFigure 2 Calibration curves for capsaicin in three different solvents: 1
ethanol. Error bars correspond to ± 1 standard deviation.different solvent systems, 10% EtOH, 95% EtOH, and
80:10:10 H2O:Tween-20:95% EtOH. CAP dissolved in all
three solvents exhibited similar absorbance, suggesting
that the solubility of CAP is similar in each solvent system
tested. Despite the similarity, CAP appeared to have the0% EtOH, 80:10:10 H2O:EtOH:Tween-20 (Tween), and 95%
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greater slope of the response curve. As CAP is completely
soluble in pure EtOH [5], the absorbance measurements
obtained from CAP in the 95% EtOH solvent system
were used to calculate the correct (or predicted) CAP
concentrations. The average ratio of the concentration
experimentally determined for CAP in 10% EtOH to
the concentration of CAP in 95% EtOH (E/P) is around
91% (Table 1). The average ratio of the concentrations of
CAP in 10% EtOH to Tween solution (E/T) is nearly 99%.
Stability of CAP in 10% EtOH solutions
To determine the stability of CAP in 10% EtOH under
different environmental conditions, a time course study
was conducted by monitoring the absorbance of CAP
solutions. The data for each of the three concentrations
monitored, 200, 350, and 500 μM CAP, are shown in
Figures 3, 4, and 5, respectively.
Of all the environments, CAP stored around 3°C and
sheltered from light yielded the most consistent absorb-
ance measurements for all three concentrations tested.
Furthermore, all three concentrations tested yielded ab-
sorbance measurements within error relative to the initial
time point for the entirety of the seven month study.
CAP solutions stored at room temperature (~23°C),
while protected from light, demonstrated a consistency
in absorbance similar to when stored at 3°C. Within error,
there was no decrease in absorbance, and therefore no
decrease in CAP solubility from 0 to 27 weeks, for all
three of the concentrations tested. The one exception to
this trend was the 12 week measurement for the 500 μM
concentration. This anomalous data point demonstrated
a decrease in intensity that is not within error of the
observed trend. Thus, both visual and statistical analysis
(by utilization of the Grubb’s test) result in the data point
being considered an outlier (P = 0.05).
CAP solutions stored at room temperature, and exposed
to light, exhibit no decrease in absorbance throughout
the entire seven months for concentrations of 200 and
350 μM. Conversely, for the highest concentration of
500 μM, there is a significant decrease in absorbance ofTable 1 CAP concentration in EtOH- vs. Tween-based
solvent systems
Concentrations (μM)
Abs at 281 nm ± 1 std. dev. (3 replicates)
95% EtOH 10% EtOH Tween Ratio (E/P)
50.0 ± 2.3 45.1 ± 3.3 43.1 ± 2.7 0.90 ± 0.08
150.0 ± 0.1 135.8 ± 4.6 137.7 ± 0.8 0.91 ± 0.03
250.0 ± 0.1 226.5 ± 8.8 232.3 ± 4.4 0.91 ± 0.05
350.0 ± 0.1 317.2 ± 3.5 326.9 ± 4.4 0.91 ± 0.01
450.0 ± 0.1 407.9 ± 20.1 421 ± 8.9 0.91 ± 0.05CAP starting after only 2 months of storage. A single
measurement for the 500 μM solution taken at the sixth
week of storage (Figure 5) shows a decrease in absorbance,
before returning to an absorbance similar to the week
prior, and then gradually decreasing to lower absorbance
as the further weeks progressed. A Grubb’s test was
again utilized, and determined that this data could be
considered an outlier (P = 0.05).
The data shown for CAP stored at −20°C, while pro-
tected from light, proved to be the least consistent, in
terms of both stability and error. The 200 μM solution
demonstrates little to no decrease in absorbance for the
first four months of storage before beginning to slowly
diminish in intensity (Figure 3). The 350 and 500 μM
solutions revealed a much sooner drop-off in intensity,
as the absorbance began to significantly decrease after
only a month (Figures 4 and 5). For the concentrations
of 200 and 350 μM, the drop in absorbance intensity
correlates with a dramatic increase in standard deviation
of the data, rendering the data questionable at best. The
measurements taken for 500 μM contain much less asso-
ciated error, and can be considered more referential.
Discussion
Studies reported by Kopec et al [6,7]. provided the
groundwork for this study of CAP solutions involving the
use of Tween as a solvent. However, this report involves a
more comprehensive comparison of Tween and EtOH-
based solutions, in terms of both solubility and stability.
Each CAP solution was comprised of only a few com-
ponents (e.g. CAP, H2O, EtOH, and Tween-20), and each
component has a different maximum absorbance in the
UV spectrum. Due to a lack of sample complexity, UV/Vis
detection was performed without prior HPLC separation,
unlike the previous study. Therefore, time of analysis
was greatly reduced. The HPLC analysis described by
Kopec et al. required 12 minutes per sample [7], whereas
an average sample analysis time with the method described
in this work was significantly faster (~3 minutes). Further-
more, there were initial concerns over the solubility of the
capsaicin, as particles large enough to scatter light were
observed in solutions stored below room temperature
during the time-course study; however, these particles
all redissolved over the course of the 2-hour warming
period and vortexing of samples before analysis. Visual
inspections of the solutions prior to analysis indicated
no turbidity. The use of a spectroscopic technique permits
non-destructive and rapid analysis of the samples, but
affords less selectivity than would be achieved with a
supplementary HPLC separation step [17]. Future studies
utilizing HPLC separation or other analytical techniques
could provide confirmation of these results.
From the results of our study, it can be concluded that
CAP solutions that are similar in solubility and stability
Figure 3 Stability of the UV absorbance measurements (λ = 281 nm) of 200 μM CAP solutions prepared in 10% EtOH, as a function of time,
for four different storage environments: −20°C (dark), 3°C (dark), 23°C (dark), 23°C (light). Error bars correspond to ± 1 standard deviation.
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EtOH-based solvents, yet lack the foul taste associated
with Tween. Kopec et al [6,7]. determined that utilization
of a solvent system of Tween-80, ethanol, and water for
preparation of CAP solutions yields better solubility andFigure 4 Stability of the UV absorbance measurements (λ = 281 nm) of
for four different storage environments: −20°C (dark), 3°C (dark), 23°C (dstability than a solvent system comprised of ethanol and
water without Tween. However, the concentration of etha-
nol in their reported solutions was only around 1%. The
primary purpose of our study was determine if preparing
capsaicin solutions in similar fashion to Kopec benefitted350 μM CAP solutions prepared in 10% EtOH, as a function of time,
ark), 23°C (light). Error bars correspond to ± 1 standard deviation.
Figure 5 Stability of the UV absorbance measurements (λ = 281 nm) of 500 μM CAP solutions prepared in 10% EtOH, as a function of time,
for four different storage environments: −20°C (dark), 3°C (dark), 23°C (dark), 23°C (light). Error bars correspond to ± 1 standard deviation.
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mended. As the reported preparation of the Tween solu-
tions did not involve any separation step, we wanted to
analyze the solutions as they would be prepared
clinically. In this respect, any aspect of dissolution that
may result in suspension/dispersion of CAP would
accurately reflect clinical implications when conducting
the test. As discussed in more detail below, no turbidity
was observed in samples ready for analysis following
their warming to room temperature and vortexing. The
present work suggests that Tween-20 yields a less than
2% increase in solubility over a solvent system of etha-
nol and water, where the ethanol concentration is 10%
rather than 1% by volume. Furthermore, regardless of
the inclusion or exclusion of Tween-20, solvent systems
safe for human consumption (i.e., less than 20% ethanol
by volume) generally demonstrate CAP concentrations
below the predicted concentration; therefore, neither
allows complete solubility.
As noted in Figure 1, there is a modest increase in
solubility as the composition of EtOH is increased from
5 to 75%; however, this difference can be easily corrected
for by dissolving additional CAP into the solution, as
described in more detail later. Thus, lower percentages of
EtOH are recommended to allow safe human inhalation,
approximately 20% or less EtOH. Therefore, we have
chosen to use 10% EtOH solutions to decrease the amount
of EtOH solvent in the inhaled vapor. Furthermore, the
concentration of CAP used for the tussigenic challengedoes not typically exceed 500 μM; [12] therefore, an in-
crease in variation between high and low EtOH composi-
tions at higher concentrations of CAP does not become a
factor.
For solutions in 10% EtOH, there is a 10% decrease in
solubility relative to the predicted solubility (Table 1);
predicted concentration is determined from absorbance
measured for CAP dissolved in the 95% EtOH solvent
system. This can be overcome by increasing, by 10%, the
amount of CAP initially dissolved in solution. Accord-
ingly, a suggested standardized sample preparation for
CAP solutions in an EtOH-based solvent system is
detailed below.
Recommendations of preparation of CAP solutions in
EtOH solvent system
In this study, we used 95% EtOH and accounted for the
impurity in our dilutions; however, the following guide-
line uses 100% EtOH to allow for easier calculation.
Note: The ethanol used must be safe for human con-
sumption and the capsaicin pharmaceutical grade.
Step 1. Dissolve solid CAP in 100% anhydrous EtOH
to create a concentrated CAP stock solution. Dissolving
0.7635 g of solid CAP (2.5 mmol) in 100 mL of 100%
EtOH will produce a 25 mM stock solution of CAP.
Step 2. Prepare the solvent for the inhaled CAP solu-
tions by diluting 100% EtOH with H2O. To create 10%
EtOH solutions, combine 100 mL of 100% EtOH with
900 mL of H2O.
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duce the desired concentration of CAP in 10% EtOH,




Where Cstock and Vstock are the concentration and vol-
ume of the CAP stock solution, and Ccap and Vcap are the
concentration and volume, respectively, of the desired
CAP solution in 10% EtOH. Recall that the initial amount
of CAP added needs to be increased by 10% to account
for the decrease in solubility associated with a 10% EtOH
solvent. Equation 1 may be utilized to prepare any desired
CAP solution, or Table 2 may provide a quick reference
for specific concentrations.
Stability of CAP in 10% EtOH solutions
The stability of solutions of CAP prepared with Tween-
80 have been previously reported [7], hence, we did not
repeat a similar investigation. Instead, we focused solely
on the stability of CAP solutions prepared in 10% EtOH,
which were diluted in HPLC-grade water rather than
saline solution.
The most pertinent findings from this study show that
the greatest stability may be achieved by storing the
specified solutions of CAP in a light-free environment,
and at a temperature of approximately 3°C. Under such
conditions, the solutions of CAP in 10% EtOH remained
stable, over a range of concentrations, for a minimum of
30 weeks (nearly 8 months, the duration of the storage
study), as seen in Figures 3 – 5. Additionally, the highly
concentrated stock solutions of CAP prepared in pure
EtOH remained stable for at least a year (the maximum
time tested) under the same conditions. This increase in
stability of non-Tween CAP solution compared to that
shown in the previous study [6,18] may be attributed to
either the use of distilled water as the dilution solventTable 2 Recommended preparation of 1 L CAP solutions
at a range of useful (tussigenic) concentrations
Desired concentration of
capsaicin in solution (μM)












500 22.00 978.00rather than saline solution, or the increase in EtOH
composition. Use of saline may destabilize the CAP
solutions causing them to degrade quicker. Alternatively,
the presence of a higher percentage of EtOH in solution
may provide greater stabilization of CAP. The drastic drop
in solubility of solutions stored at −20°C might be due to
the low temperature causing some CAP to precipitate out
of solution and adsorb to the walls of the container, and
then not redissolve once the solution is brought back up
to room temperature and vortexed.
Conclusions
In this study, we demonstrated that CAP solutions pre-
pared in a 10% EtOH solvent system are nearly as soluble
as CAP solutions prepared in a Tween-incorporated solvent
system. Although neither solvent system allows complete
solubility of CAP, the concentrations that can be achieved
are quite adequate for tussigenic challenges. Therefore, to
avoid the foul taste of Tween and still efficiently prepare
soluble CAP solutions in 10% EtOH, a simple equation
may be followed (Equation 1). In this work, we have pro-
vided the groundwork for creating a standardized approach
to preparing CAP solutions for use in tussigenic challenges.
Until further refined methods are established, the preceding
preparation steps should be taken to achieve maximum
solubility of CAP in solution. Similarly, for optimal storage,
keep solutions shielded from light and at a temperature of
around 3°C.
Ongoing studies were performed utilizing the Tween-
free methods for preparing capsaicin solutions to elicit
cough (unpublished results). Tween-free 50–500 μM
capsaicin solutions were prepared in 90% physiological
saline and 10% ethanol. These solutions were used to
elicit cough in normal subjects. These solutions were
used immediately after preparation and after storage for
1–4 months, either refrigerated or at room temperature.
No differences as a function of vehicle solution (90%
physiological saline, 10% ethanol vs 80% physiological
saline, 10% Tween 20, and 10% ethanol), storage time, or
storage temperature were observed for capsaicin elicited
cough threshold, cough number, Urge-to-Cough Threshold,
and Urge-to-Cough sensitivity compared to prior studies
[13,19,20] for equal concentrations of capsaicin. There
appears to be fewer vehicle elicited coughs with 90%
physiological saline and 10% ethanol solutions compared
to 80% physiological saline, 10% Tween 20, and 10%
ethanol solutions. Future studies are required to system-
atically compare the cough response to capsaicin using
these vehicle (90% physiological saline, 10% ethanol vs
80% physiological saline, 10% Tween 20, and 10% ethanol)
solutions.
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